Abstract
Paracoccidioidomycosis (PCM) is a notable fungal infection restricted to Latin America. Since the first description of the disease by Lutz up to the present day, Brazilian researchers have contributed to the understanding of the life cycle of this pathogen and provided the possibility of new targets for antifungal therapy based on the structural and functional genomics of Paracoccidioides. In this context, in silico approaches have selected molecules that act on specific targets, such as the thioredoxin system, with promising antifungal activity against Paracoccidioides. Some of these are already in advanced development stages. In addition, the application of nanostructured systems has addressed issues related to the high toxicity of conventional PCM therapy. Thus, the contribution of molecular biology and biotechnology to the advances achieved is unquestionable. However, it is still necessary to transcend the boundaries of synthetic chemistry, pharmaco-technics, and pharmacodynamics, aiming to turn promising molecules into newly available drugs for the treatment of fungal diseases.
Funder
Fundação de Apoio à Pesquisa do Distrito Federal
Subject
Plant Science,Ecology, Evolution, Behavior and Systematics,Microbiology (medical)
Reference207 articles.
1. A pseudococcidic mycosis localized in the mouth and observed in Brazil. A contribution to the knowledge of the American hyphoblastomycoses (in Portuguese);Lutz;Brazil-Medico,1908
2. Evolução dos Conhecimentos Sobre a Paracoccidioidomicose. Um Pouco de Sua História;Lacaz,1982
3. Estudos comparativos do granuloma coccidiótico nos Estados Unidos e no Brasil: Novo gênero para o parasito brasileiro;Almeida;An. Fac. Med. Sao Paulo,1930
4. Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues
5. Brazilian guidelines for the clinical management of paracoccidioidomycosis
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献